Keywords
thromboelastography
hip replacements
How to Cite
Abstract
Introduction: Thromboelastography (TEG) and antifibrinolytic drugs are useful in the diagnosis and management of patients undergoing major orthopedic surgery to reduce perioperative bleeding and transfusion requirement. We described the effect of tranexamic acid on thromboelastography parameters.
Methods: In 20 patients undergoing major orthopedic surgery, a dose of 20 mg/kg tranexamic acid followed infusion 1 mg/kg/h until the end of the procedure was administered. Two TEG were performed; baseline and a control at the end of the procedure. Thromboelastography effects are described.
Results and Conclusions: No fibrinolysis was observed in the samples taken, however in 75% of patients increased the alpha angle suggesting a higher speed in clot formation; which might suggest a different mechanism of action of Tranexamic Acid as pro coagulant. Factors such as gender and age may modify the baseline TEG. The surgical time and the type of surgery are critical in bleeding and blood product requirement.
Foss NB, Kehlet H. Hidden blood loss after surgery for hip fracture. J Bone Joint Surg Br. 2006;88:1053-9.
Dahl OE, Pedersen T, Kierulf P, Wesvik AB, Lund P, Arnesen H, et al. Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res. 1993;70:451-8.
Klein HG, Spahn DR, Carson JL. Red blood cell transfusion in clinical practice. Lancet. 2007;370:415-26.
Zufferey P, Merquiol F, Laporte S, Decousus H, Mismetti P, Auboyer C, et al. Do antifibrinolytics reduce allogeneic blood transfusion in orthopedic surgery? Anesthesiology. 2006;105(5):1034-40.
Ekback G, Axelsson K, Ryttberg L, Edlund B, Kjellberg J, Weckström J, et al. Tranexamic acid reduces blood loss in total hip replacement surgery. Anesth Analg. 2000; 91(5):1124-30.
Gill JB, Rosenstein A. The use of antifibrinolytic agents in total hip arthroplasty. J Arthroplasty. 2006;21:869-73.
Rivera D, Pérez A. Técnicas de ahorro sanguineo en cirugía. Rev Col Anest. 2012;39(4):545-59.
Roberts I, Shakur H, Ker K, Coats T; CRASH-2 Trial collaborators. Antifibrinolytic drugs for acute traumatic injury. Cochrane Database Syst Rev. 2011 Jan 19;(1):CD004896. doi:10.1002/14651858.CD004896.pub3.
Raffán SF, Ramírez FJ, Cuervo JA, et al. Tromboelastografía. Rev Col Anest. 2005;33:181-86.
Shore-Lesserson L, Heather EM, Marietta D. Thromboelastography guided therapy algorithm reduces transfusion in complex cardiac surgery. Anesth Analg. 1999;88:312-9.
Brenni M, Worn M, et al. Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. Acta Anaesthesiol Scand. 2010;54:111-7.
Roeloffzen W, Kluin-Nelemans HC, Mulder AB, Veeger NJ, Bosman L, de Wolf JT. In normal controls, both age and gender affect coagulability as measured by thrombelastography. Anesth Analg. 2010;110(4):987-94.
Kwok FG. Changes in Thrombelastograph variables associate with age. Anesth Analg. 1999;2:449-54.
Kish RF, Naddafnia H, Ghorbanloo M, et al. Thromboelastography analysis after autologous transfusion in patients undergoing coronary artery bypass surgery. Iranian Heart Journal [internet]. 2009;10(4):19-27. Disponible en: http://www.sid.ir/en/VEWSSID/J_pdf/86820090403.pdf.
Roeloffzen WW, Kluin-Nelemans HC, Bosman L, de Wolf JT. Effect of red blood cells on hemostasis. Transfusion. 2010;50(7):1536-44.
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.